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A B S T R A C T
Background: There are conﬂicting theories regarding the use of percutaneous coronary intervention (PCI)
of isolated severe proximal left anterior descending (LAD) artery stenosis in place of left internal
mammary artery grafting in diabetic patients. The aim of this study was to investigate the effect of PCI on
left ventricular function and determine difference between diabetics and non-diabetics.
Methods: A prospective study was conducted on 50 patients with isolated severe proximal LAD stenosis:
23 diabetic and 27 non-diabetic patients. Successful PCI with everolimus-eluting stents was performed
for all of the patients. These patients underwent transthoracic echocardiography within 24 h before and
1 month after PCI, and alterations in the left ventricular parameters were compared between the two
groups.
Results: There was a signiﬁcant 12% increment in the mitral annular peak systolic velocity (s0) (p = 0.02),
21% decrement in the trans mitral early ﬁlling deceleration time (DT) (p < 0.001), 10% decrement in the
systolic left ventricular internal dimension (LVIDs) (p = 0.002), signiﬁcant increment in the left
ventricular ejection fraction (LVEF) (p = 0.004), and signiﬁcant decrement in the left atrial diameter
(p = 0.006) in the diabetic patients after performing PCI. Conversely, the non-diabetic patients showed a
statistically signiﬁcant 14% increase in the DT, 6.3% decrease in the s0 velocity, 8% increase in the LVIDs,
signiﬁcant increment in the left atrial diameter and no change in LVEF after PCI.
Conclusion: Our study demonstrated that everolimus-eluting stents favorably improved the markers of
left ventricular systolic and diastolic function in diabetic patients with isolated severe proximal LAD
stenosis compared with those of non-diabetic patients with the same condition.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In total, 15–20% of patients who undergo coronary revasculari-
zation are diabetic.1 The long-term results of percutaneous
coronary intervention (PCI) and coronary artery bypass graft are
less desirable in diabetic patients. This outcome is most likely due to
a faster progression of atherosclerosis and a higher rate of
restenosis. While the use of stents has improved the short- and
long-term outcomes of PCI in diabetic patients, the consequences of* Corresponding author at: Department of Cardiology, Fatemeh Zahra Teaching
Hospital, Faculty of Medicine, Mazandaran University of Medical Sciences, Artesh
Boulevard, Sari 48188-13771, Iran.
E-mail address: Dr.mr.nabati@gmail.com (M. Nabati).
Please cite this article in press as: Nabati M, et al. Alterations in echoca
stenting in diabetic patients with isolated severe proximal left ant
dx.doi.org/10.1016/j.ihj.2016.08.004
http://dx.doi.org/10.1016/j.ihj.2016.08.004
0019-4832/ 2016 Published by Elsevier B.V. on behalf of Cardiological Society of
creativecommons.org/licenses/by-nc-nd/4.0/).PCI are still less favorable in diabetics compared with non-diabetic
patients. New angioplasty techniques, such as drug-eluting stents,
most likely have a critical role in improving the results of PCI in
diabetic patients. Thus, there are indications for angioplasty in
diabetics to be extended even more in the near future.2 Echo
Doppler studies have reported that patients with asymptomatic left
ventricular (LV) diastolic dysfunction have a higher incidence of all-
cause mortality. Mild diastolic dysfunction and moderate to severe
dysfunction were associated with 8.3-fold and 10.2-fold increased
risks of mortality, respectively. The overall mortalities of symp-
tomatic patients with diastolic or systolic heart failure are very
similar.3 Trans mitral Doppler ﬂow velocities have previously been
used for evaluating the variations in LV diastolic function after PCI.4
The left atrial (LA) diameter, early ﬁlling deceleration time (DT),
E/e0 ratio and peak atrial reversal ﬂow velocity of the pulmonaryrdiographic left ventricular function after percutaneous coronary
erior descending artery stenosis, Indian Heart J. (2016), http://
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index of LV relaxation. Additionally, the LV ejection fraction (LVEF),
regional LV wall motion and peak systolic velocity (s0) of the mitral
annulus have been used as an index of the global LV systolic
function. Few studies have compared the echocardiographic
systolic and diastolic parameters between diabetics and non-
diabetics after PCI on left anterior descending (LAD) artery. These
studies showed that PCI on LAD induced more increase in LVEF
compared with angioplasty on other vessels. Furthermore,
existence of DM did not have negative effect in LVEF improvement
after angioplasty on LAD. However, other systolic and diastolic
variables were not separately compared between diabetic and
non-diabetic patients.5 Improvements in systolic and diastolic LV
function are associated with better outcome and functional
capacity.
Therefore, our study was designed to determine the changes in
LV systolic and diastolic function after successful PCI and drug-
eluting stenting of isolated stenosis of the proximal LAD artery in
diabetic patients compared with non-diabetic patients.
2. Methods
2.1. Patients
From 2012 to 2013, a prospective clinical study was conducted
in the Fatemeh Zahra teaching hospital. In total, 23 consecutive
elective diabetic patients were considered for enrollment who
presented with typical chest pain and documented myocardial
ischemia with a considerable amount of anterior or anteroseptal
ischemia on single-photon emission computerized tomography
and who underwent successful angioplasty after displaying
isolated severe proximal LAD coronary artery stenosis (>75%
luminal diameter) in a recent angiography. Additionally, 27 non-
diabetic patients were assigned to the control group. Then,
alterations in the echocardiographic variables after the procedure
were compared between the two groups.
The study was performed according to the guidelines of the
Helsinki Declaration and was approved by the ethics committee of
the hospital. Written informed consent was obtained from all of
the patients. Patients with lesions in the ﬁrst diagonal branch, total
occlusion of the LAD or multivessel coronary artery disease were
excluded from our study. None of the study patients had
congenital, signiﬁcant valvular heart disease (equal or more than
moderate severity) or cardiomyopathy and atrial ﬁbrillation.
Additionally, patients with systemic diseases, such as cancer,
collagen vascular diseases or amyloidosis, were excluded.
2.2. Echocardiography
Transthoracic echocardiography was performed at baseline
within 24 h before PCI and was repeated 1 month after PCI for all
patients by a Vivid S5 (GE Healthcare, Wauwatosa, WI, USA),
1–3 MHz transducer. All of the measurements represent the average
of three consecutive beats between normal heart rate ranges,
60–100 beat per minute. The images were stored on a hard disk for
better ofﬂine measurements, and the results were conﬁrmed by an
echocardiographer who was blind to the patient’s information.
Patients with a poor echo window were excluded from the study.
Estimates of the LV systolic and diastolic dimensions were
derived from the LV minor-axis dimensions with the transducer in
the parasternal position so that the cursor was perpendicular to the
interventricular septum and posterior wall at the mid-papillary
muscle level. The EF and wall motion abnormalities (WMA) were
determined. The EF was deﬁned as the end diastolic volume minus
the end systolic volume divided by the end diastolic volume from
biplane apical two and four chamber views using a modiﬁedPlease cite this article in press as: Nabati M, et al. Alterations in echoca
stenting in diabetic patients with isolated severe proximal left ant
dx.doi.org/10.1016/j.ihj.2016.08.004Simpson’s technique. To assess the reproducibility of determina-
tion of EF by a modiﬁed Simpson’s technique, this index was
measured in 10 randomly selected patients and was repeated 1 day
later to calculate the intra-observer correlation coefﬁcients, which
was found to be 0.94.
Pulse Doppler recordings of the diastolic trans mitral ﬂow
velocity were obtained with the sample volume located at the tips
of the mitral leaﬂets from the apical four chamber view. The peak
early diastolic velocity (E wave), peak late diastolic velocity
(A wave), early ﬁlling DT and E/A velocity were measured. Tissue
Doppler imaging of the mitral annulus was obtained from the
apical four chamber view. A 5 mm sample volume was placed at
the septal and lateral mitral annuli. The following measurements
were determined: the peak systolic velocity (s0) and early diastolic
velocity (e0). An analysis was performed for the average of each
velocity at the two annular sites. Then, the E/e0 ratio was calculated.
The pulmonary venous ﬂow velocity proﬁle was obtained from an
apical four chamber view. The pulse Doppler sample volume was
placed 1 cm into the pulmonary vein, and the peak systolic ﬂow
velocity (S wave), peak diastolic velocity (D wave) and peak atrial
reversal ﬂow velocity (AR) were determined. The LA diameter was
measured in the parasternal long-axis view from a 2D image at end
systole.
Blood samples were obtained during fasting, and the levels of
plasma glucose, total cholesterol (T-chol), high density lipoprotein
(HDL)-chol, low density lipoprotein (LDL)-chol, and triglycerides
(TG) were measured. The systolic and diastolic blood pressures
were measured after 5 min of rest. The height and weight were
measured, and the body mass index (BMI) was calculated as the
body weight divided by the height squared. Hypertension was
deﬁned as a systolic blood pressure 140 mmHg, a diastolic blood
pressure 90 mmHg6 or the requirement for antihypertensive
medication. The diabetes mellitus (DM) was deﬁned according to
the criteria of the American Diabetes Association7 or the
requirement for insulin or oral hypoglycemic drugs. A family
history of coronary artery disease (CAD) was deﬁned as having a
ﬁrst-degree relative (a male <55 years or female <65 years) with a
history of myocardial infarction, coronary revascularization, or
sudden death.8 The history of smoking was determined by a face-
to-face questionnaire.
Coronary angiography was performed for all of the patients
using a cardiac angiography system (Siemens AG, Medical
Solutions, Erlangen, Germany), and they all underwent PCI. PCI
was performed by standard techniques, and XIENCE stents
(Everolimus-Eluting Coronary Stent System, Santa Clara, CA,
USA) were used.
Procedural success was deﬁned as the successful deployment of
the stent and residual stenosis of less than 30%.9 Procedural
anticoagulation was achieved with unfractionated heparin;
glycoprotein IIb/IIIa inhibitors were used whenever needed.
Patients received 300 mg of aspirin before the intervention. A
300 mg oral dose of clopidogrel was recommended before the
procedure. Thereafter, 80 mg of aspirin and 75 mg of clopidogrel
were prescribed daily. Other standard drugs (angiotensin con-
verting enzyme inhibitors, beta blockers, statins and oral
hypoglycemic agents) remained unchanged during the study in
order to minimize the effects of alterations on the echocardio-
graphic variables.
2.3. Statistical analysis
Continuous variables are expressed as the mean  SD. Percent-
age changes in all of echocardiographic variables following PCI were
determined. These variables were considered as new variables,
separately. Then, two groups were compared for these new variables
by an independent t-test. Paired-samples t were used for comparingrdiographic left ventricular function after percutaneous coronary
erior descending artery stenosis, Indian Heart J. (2016), http://
Table 1
Demographics and measurements of common cardiovascular risk factors of
subjects categorized as having or not having diabetes mellitus.
Non-diabetics Diabetics p value
Gender
Male 19 (70.4%) 7 (30.4%) 0.01
Female 8 (29.6%) 16 (69.6%)
Hypertension 16 (59.3%) 18 (78.3%) 0.225
Cigarette smoking 6 (22.2%) 2 (8.7%) 0.261
Family history 5 (18.5%) 10 (43.5%) 0.07
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For determining normality, we evaluated each variable individually in
both groups, separately by Shapiro–Wilk test. For variables that were
non-normally distributed, the Mann–Whitney U test was used.
Categorical variables were compared with a Chi-squared test. A
p < 0.05 was considered to be statistically signiﬁcant. Well known
CAD risk factors were included in a logistic regression model of CAD
(for those who demonstrated statistically signiﬁcant difference
between two groups).
All of the statistical calculations were performed using SPSS/
PASW (Predictive Analytics SoftWare) Statistics 18 (SPSS Inc.,
Chicago, IL, USA). The sample numbers were determined by
previous studies with the following statistical formula (according
to standard deviation of time variable in Table 2 of Ref. 4):
n1 ¼ n2 ¼
2ðZ1ða=2Þ þ Z1bÞ2s2
e2
¼ 21
a ¼ 0:05
b ¼ 0:2
s2 ¼ 49
e ¼ 6
3. Results
A total of 24 women and 26 men were enrolled in the study. The
mean age was 57.68  8.8 years. Within the study population,
23 patients (46%) were diabetic; 8 patients (16%) were smokers;
15 patients (30%) had a positive family history of CAD; and 34 patients
(68%) were hypertensive. The demographics and measures of
common cardiovascular risk factors of the study population and
the study group categorized by having or not having DM are
presented in Tables 1 and 2. An independent t-test did not show any
statistically signiﬁcant difference for age between two groups.
Therefore, we used this test for determining differences between
two groups.
We assessed the association between the DM and the variables
related to cardiovascular risk factors by a Chi-squared test. No
signiﬁcant correlation was found for smoking (p = 0.261), hyper-
tension (p = 0.225), or a family history of CAD (p = 0.07). The
correlations between the DM and fasting blood sugar (FBS), TG,Table 2
Demographics and measurements of common cardiovascular risk factors of study popu
Whole study population Non-diabetics (n = 
Mean SD Mean 
Age (y) 57.68 8.82 59.6296 
FBS (mg/dl) 144.22 79.25 100.7692 
TG (mg/dl) 212.69 128.79 207.1923 
CHOL (mg/dl) 184.83 50.21 184.4231 
HDL (mg/dl) 43.89 18.05 41.9615 
LDL (mg/dl) 102 21.05 104.2308 
BMI (kg/m2) 26.76 3.93 26.1259 
SD: standard deviation, FBS: fasting blood sugar, TG: triglycerides, CHOL: cholesterol, H
Please cite this article in press as: Nabati M, et al. Alterations in echoca
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dx.doi.org/10.1016/j.ihj.2016.08.004T-chol, HDL-chol, LDL-chol and BMI levels (evaluated by an
independent t-test, Levene’s test for equality of variances) were
analyzed. There was signiﬁcant correlation between the DM and
FBS level (p < 0.001). However, there was not a signiﬁcant
correlation between the DM and TG levels (p = 0.754), T-chol
levels (p = 0.95), HDL-chol levels (p = 0.43), LDL-chol levels
(p = 0.43), or BMI levels (p = 0.22). In diabetics, glycated hemoglo-
bin level (HbA1c) was 7.83  2.61% and 7.37  2.87% before and
after PCI, respectively. This was not statistically signiﬁcant (p = 0.5).
There were statistically insigniﬁcant differences (p = 0.36) in the
percentage diameter stenosis of LAD before the PCI between the non-
diabetics (91  9.91%) and diabetics (87.5  12.3%).
Again, after performing PCI, these differences were not
signiﬁcant (residual stenosis of 6  6.4% in non-diabetics and
4.1  5.9% in diabetics; p = 0.37). Additionally, the stent diameter was
2.8  0.26 mm in non-diabetics and 2.7  0.29 mm in diabetics
(p = 0.33); the stent length was 23.9  6.8 mm in non-diabetics
and 25  9.25 mm in diabetics (p = 0.72), and the stent number was
1.05  0.22 in non-diabetics and 1.06  0.25 in diabetics (p = 0.9). For
determining normality, we evaluated each variable individually in
both groups, separately by Shapiro–Wilk test. LVEF, LA diameter and
E/A ratio were not normally distributed. For these variables that were
non-normally distributed, the Mann–Whitney U test was used.
When comparing differences between the two groups after the
procedure by an independent samples t-test (Table 3), diabetic
patients showed that the systolic left ventricular internal
dimension (LVIDs) decreased by 10% and s0 velocity increased by
12%. Additionally, there was a 21% decrement in the DT in these
patients. All of these data were statistically signiﬁcant. Further-
more, they showed statistically signiﬁcant increases in the LVEF
(median 5%, 95% conﬁdence interval [2.5–7.5%], p = 0.004) and
signiﬁcant decreases in LA diameter (median 0.1 cm, 95%
conﬁdence interval [0.25 to 0.1 cm], p = 0.006). Conversely, the
non-diabetic patients showed a statistically signiﬁcant 8% increase
in the LVIDs, a 14% increase in the DT, and a 6.3% decrease in the s0
velocity. Also, there was signiﬁcant increase in LA diameter
(median 0.11 cm, 95% conﬁdence interval [0.085–0.3 cm],
p = 0.006). LVEF did not change in non-diabetics (median 0%,
95% conﬁdence interval [2.5 to 2.5%], p = 0.004). More females
(69.6%) were included in the diabetic group. Conversely, more men
(70.4%) were present in the non-diabetic group.
We evaluated the potential confounding effect of gender by
multiple regression analysis, separately. It showed that con-
founding effect of gender was not statistically signiﬁcant (EF:
p = 0.59 for sex, p = 0.012, B = 6.76, 95% conﬁdence interval
[1.55–11.96] for DM, DT: p = 0.35 for sex, p = 0.001, B = 89.24,
95% conﬁdence interval [139.18 to 39.30] for DM, LA
diameter: p = 0.54 for sex, p = 0.014, B = 0.275, 95% conﬁdence
interval [0.49 to 0.059] for DM, LVIDs: p = 0.74 for sex,
p = 0.007, B = 0.53, 95% conﬁdence interval [0.92 to 0.15] for
DM). Regarding the e0 velocity alteration, the paired samples
t-test showed a signiﬁcant increase in the e0 velocity after PCI inlation and subjects by study group.
27) Diabetics (n = 23) p value
SD Mean SD
9.38963 55.3913 7.69734 0.091
11.94088 195.5909 93.73248 <0.001
148.63351 218.9130 104.93674 0.754
49.92248 185.3043 51.65835 0.95
9.20209 46.0870 24.60767 0.43
20.36724 99.3636 22.00767 0.43
4.09320 27.5253 3.69471 0.22
DL: high density lipoprotein, LDL: low density lipoprotein, BMI: body mass index.
rdiographic left ventricular function after percutaneous coronary
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diabetics (p = 0.09) separately. However, when the two groups
were compared by an independent samples t-test, there was no
signiﬁcant difference in the e0 velocity improvement between
diabetics and non-diabetics (p = 0.3). Furthermore, the diastolic
left ventricular internal dimension (LVIDd), AR, E/i (diabetics:
median 0.068, 95% conﬁdence interval [0.1 to 0.2], non-
diabetics: median 0.116, 95% conﬁdence interval [0.07–0.15],
p = 0.4), S/D and E/e0 did not change signiﬁcantly after performing
PCI between the diabetic and non-diabetic groups.
Before PCI, the WMA was observed in 2.2  2.91 segments that
signiﬁcantly decreased to 1.5  2.58 segments (p = 0.04) after the
procedure. However, there was no signiﬁcant difference in WMA
improvement between the diabetics and non-diabetics, (before PCI:
2.69  2.96 and 1.77  2.86 and after PCI: 1.69  2.9 and
1.33  2.24 segments, respectively, p = 0.4).
4. Discussion
Stents control two of the three mechanisms of restenosis: the
initial elastic recoil and late remodeling. However, they cannot
reduce intimal hyperplasia; indeed, stents may increase it.2 The
introduction of stents that release drugs with inhibition effects on
intimal hyperplasia may reduce or eliminate the main limitation of
angioplasty.10 Polymer-based paclitaxel-eluting stents and siroli-
mus-eluting stents have been shown to signiﬁcantly reduce
angiographic restenosis in comparison with bare metal stents.
However, the rates of primary stent thrombosis are increased.
With the goal of further augmenting the security and effect of DES,
an everolimus-eluting stent (EES) has been designed.11 Diabetic
patients with CAD experience worse outcomes compared with
those without diabetes mellitus. In the absence of multivessel or
left main CAD, PCI is a simple and efﬁcient technique for
revascularizing involved coronary arteries in these patients. Lower
probability of repeat revascularization and stent thrombosis with
DES have inﬂuenced selected options of revascularization for
diabetic patients. This is particularly useful with the second
generation of DES using everolimus.12
In a 14-day rabbit iliac model, the endothelialization over the
stent struts was more rapid with the EES than with the stents
eluting sirolimus, zotarolimus, or paclitaxel.13 In 2000, Bayata
et al.4 evaluated the early effect of PCI on LV diastolic dysfunction
in 30 patients with isolated severe LAD stenosis. All of the
measurements were performed within 4 h before PCI and repeated
within 24 h after angioplasty. After angioplasty, none of the
parameters (DT, isovolumic relaxation time, E/A and E wave transit
time), except for the A wave transit time, were changed
signiﬁcantly. However, the tissue Doppler study and the calcula-
tion of the EF, LV and LA diameter were not included in this study.
Additionally, the effects of common cardiovascular risk factors,
such as DM, were not determined. Furthermore, stenting was not
performed for all of the patients.
In 2013, Mehrpooya et al.5 assessed the effects of PCI on LVEF
and WMA in 40 patients who presented with ischemic cardiac
chest pain, an ejection fraction less than 40%, and signiﬁcant
coronary occlusion (70%). Echocardiography was performed at
baseline and one month after the procedure. The mean EF
increased signiﬁcantly after angioplasty (p < 0.000). All of the
patients (100%) had wall motion abnormality at baseline, but the
frequency decreased to 65% of them after the procedure. The
improvement of EF in patients with signiﬁcant stenosis of the LAD
was higher than in patients without LAD lesions (p = 0.008).
In 2005, Agirbasli et al.14 evaluated LV contractility and
myocardial perfusion after PCI in 60 patients who underwent
successful LAD stenting. Myocardial perfusion and LVEF improved
at 6  3 months after the procedure (p = 0.05). Patient-related factors,rdiographic left ventricular function after percutaneous coronary
erior descending artery stenosis, Indian Heart J. (2016), http://
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IHJ-1031; No. of Pages 5such as DM, presentation with acute coronary syndrome and age, did
not affect the LVEF change after the procedure.
Impaired LV relaxation is the earliest manifestation of
myocardial ischemia. The primary abnormality of myocardial
relaxation is characterized by a decrease in the E wave velocity, an
increase in the A wave velocity and E/A ratio, and an increase in the
DT and AR velocity. Later, it is followed by an increase in the LA
diameter. The LA acts as a conduit between the pulmonary vascular
bed and the LV. In addition, the atrium acts as an efﬁcient volume
sensor, releasing natriuretic peptides and other neurohormones
into the circulation as a consequence of increased atrial wall stress.
Thus, when the LA empties against a noncompliant LV and/or there
is an increase in the LV end-diastolic pressure, the LA pressure will
rise. This pressure is poorly tolerated by the thin wall of the LA, and
subsequent dilation will occur. Chronic LA pressure overload will
eventually cause LA wall ﬁbrosis. Indeed, LA size can be considered
a biomarker of sustained elevations in LV ﬁlling pressures.15
Additionally, a decrease in the early diastolic mitral annular
motion (e0) is related to a decreased LV elastic recoil, which is noted
as an early sign of ischemia and impaired relaxation. In contrast, LV
systolic function is an important predictor of prognosis, and
parameters that represent systolic function, such as the LVEF,
WMAs and LVIDs and LVIDd, can be used for predicting out-
comes.16 Recently, mitral annular systolic motion (s0) was
introduced as a method for measuring LV systolic function.
Cardiac disorders can disturb both longitudinal and radial
contractile function. However, longitudinal function is impaired
initially. Therefore, the longitudinal contractile function of the
annulus (s0) can be useful in earlier diagnosis of ischemia.17
In our study, diabetics showed signiﬁcant improvement in the
systolic LVID, LA diameter, DT, EF and s0 velocity compared with
non-diabetics. At baseline, most of these parameters were worse in
diabetics compared with non-diabetics. This outcome may be due
to a worse effect of ischemia in diabetics. However, our study also
showed excellent reversibility of these adverse effects after PCI in
this subgroup. In non-diabetics, there was not any change in LVEF
after PCI. WMA improvement was observed in both diabetics and
non-diabetics. Additionally, in spite of increased DT after perform-
ing PCI in non-diabetics, it remained in a category of impaired
relaxation (Grade I of diastolic dysfunction) with normal ﬁlling
pressure. The decreased s0 velocity in non-diabetics may be due to
hibernated myocardium, micro embolization or microvascular
dysfunction. Regarding the explanation for such a possible
difference in the LV function improvement with PCI in LAD
between diabetic and non-diabetic patients, baseline echocardio-
graphic variables were signiﬁcantly worse in diabetic patients.
Another possible explanation may be ‘‘chance’’ in view of the small
sample data.
A limitation of our study was the small sample size. Additionally,
there were more females in the diabetic group compared with the
non-diabetic group. However, we tried to modulate the confound-
ing effect of gender with statistical analyses. Another limitation was
the use of the LV and LA diameters instead of the volume. Our
follow-up period was one month after PCI.
It was in concordance with previous similar studies such as
Bayata and Mehrpoya that their follow up periods were 24 h and
one month after angioplasty, respectively. It seems that shorter
follow up period may minimize confounding effect of time on
echocardiographic variables. In conclusion, our study showed thatPlease cite this article in press as: Nabati M, et al. Alterations in echoca
stenting in diabetic patients with isolated severe proximal left ant
dx.doi.org/10.1016/j.ihj.2016.08.004EES favorably improved markers of LV systolic function, such as the
LVIDs, s0 velocity and EF, in diabetics compared with non-diabetics.
Additionally, there were signiﬁcant improvements in the LA
diameter and DT, which are markers for LV diastolic function.
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